Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Gain Therapeutics Inc GANX

Healthcare Biotechnology
Gain Therapeutics, Inc. is a biotechnology company. The Company is focused on developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company’s drug... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GANX)

Gain Therapeutics To Present At Biotech Showcase 2025

GlobeNewswire 11 days ago

Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

GlobeNewswire November 14, 2024

Gain Therapeutics Presents Data at 36ᵗʰ EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2

GlobeNewswire October 23, 2024

Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

GlobeNewswire October 15, 2024

Gain Therapeutics to Present at Michael J. Fox Foundation's 16th Annual Parkinson's Disease Therapeutics Conference

GlobeNewswire October 9, 2024

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024

GlobeNewswire October 7, 2024

Gain Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire October 3, 2024

Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson's Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers

GlobeNewswire September 30, 2024

Gain Therapeutics To Host Virtual Webinar on Results From Phase 1 Study and Design of Upcoming Phase 1b Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease

GlobeNewswire September 26, 2024
View More News ››

Opinion & Analysis (NDAQ:GANX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GANX)

S&P 500 Edges Lower; RH Shares Plunge After Q1 Results | Ben

News; $GANX S&P 500 Edges Lower; RH Shares Plunge After Q1 Results | BenzingaU.S. stocks traded mixed toward the trading, with the...
whytestocks - June 14, 2024

Gain Therapeutics Presents Data at the AD/PD(TM) 2024 Confer

News; $GANX Gain Therapeutics Presents Data at the AD/PD(TM) 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its...
whytestocks - March 5, 2024

New year update from GANX ceo!

https://youtu.be/S3rGQQxSzq0?si=lH0Q0ZZo8-PupT60
BryceCanada - January 11, 2024

New video discussing clinical trials!

https://youtu.be/XEfhw9LCOQY?si=m7PVyM7QqLfStwJq
BryceCanada - October 12, 2023

Excellent interview from Gain CEO

https://youtu.be/dpoZqf702Bs?si=5DePuhTniqTiYMLH
BryceCanada - September 7, 2023
View more Bullboard ››

Cascadia Minerals Ltd

Cascadia Minerals Ltd

Cascadia is a Canadian junior mining company focused on exploring for copper and gold in the Yukon and British Columbia ...
View More »